Moderna Inc (NASDAQ:MRNA)
| 131.04 Delayed Data As of Jan 22 |  -1.94 / -1.46%Today’s Change | 17.91 Today|||52-Week Range 178.50 | +25.43% Year-to-Date |
Latest MRNA News | Press Releases
| Why Pfizer's Future Looks Better in 2021 2:30pm / MotleyFool.com - Paid Partner Content | Could Moderna Be a Millionaire-Maker Stock? Jan 23 / MotleyFool.com - Paid Partner Content |
| What Are Moderna's Risks? 6:10am / MotleyFool.com - Paid Partner Content | Is This Under-the-Radar COVID Stock the Next Moderna? Jan 23 / MotleyFool.com - Paid Partner Content |
| How Are COVID Vaccine Rollouts Going in Europe? Jan 23 / MotleyFool.com - Paid Partner Content | Why Moderna's COVID Vaccine Is Just the Tip of the Iceberg Jan 23 / MotleyFool.com - Paid Partner Content |
| What Does 2021 Hold for BioNTech Stock? Jan 23 / MotleyFool.com - Paid Partner Content | Top Coronavirus Vaccine Makers Will Earn Up to $23 Billion in Revenue This Year, Says New Analysis Jan 22 / MotleyFool.com - Paid Partner Content |
| Here Are the Biggest Hurdles for COVID Vaccinations Jan 23 / MotleyFool.com - Paid Partner Content | VBI Vaccines (VBIV) Provides Updates on COVID-19 Vaccine Jan 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 132.98 |
| Today’s open | 124.56 |
| Day’s range | 128.91 - 135.83 |
| Volume | 355,324 |
| Average volume (3 months) | 18,239,712 |
| Market cap | $51.9B |
Data as of 6:30pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | +68.63% |
| Earnings growth (this year) | -0.11% |
| Earnings growth (next 5 years) | +33.60% |
| Revenue growth (last year) | -55.42% |
| P/E ratio | NM |
| Price/Sales | 107.47 |
| Price/Book | 37.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +1.47 | +0.36% |
| BIIBBiogen | -0.73 | -0.27% |
| EXASExact Sciences Corp | +2.01 | +1.36% |
| ---- |
Data as of 7:21pm ET, 01/22/2021
Financials
| Next reporting date | March 10, 2021 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $60.2M |
| Annual profit (last year) | -$514.0M |
| Net profit margin | -853.73% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
